Ignite Creation Date:
2024-05-06 @ 3:45 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02364726
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2015-02-10
Brief Title:
Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients A Pilot Study
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out the effects of acupuncture on reducing nerve damage
Acupuncture is a medical technique of inserting very thin needles into the energy points on the body with the aim to restore health and well-being It has been used widely to treat pain such as lower back pain and joint pain In this study the investigators will assess if acupuncture can be used to ease the pain tingling and numbness that may be caused by chemotherapy and improve quality of life during chemotherapy
Acupuncture is a medical technique of inserting very thin needles into the energy points on the body with the aim to restore health and well-being It has been used widely to treat pain such as lower back pain and joint pain In this study the investigators will assess if acupuncture can be used to ease the pain tingling and numbness that may be caused by chemotherapy and improve quality of life during chemotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None